Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Urologic Oncology|May 16, 2002
Nomograms and instruments for the initial prostate evaluation: the ability to estimate the likelihood of identifying prostate cancerMakoto Ohori, Peter Swindle
The Journal of Urology|May 16, 2006
Laparoscopic radical prostatectomy for localized prostate cancer: a systematic review of comparative studiesRebecca Tooher, Peter Swindle, Henry Woo, et al.
Magma (New York, N.Y.)|September 18, 2008
Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathologyPeter Swindle, Saadallah Ramadan, Peter Stanwell, et al.
Radiology|July 2, 2003
Pathologic characterization of human prostate tissue with proton MR spectroscopyPeter Swindle, Simon McCredie, Peter Russell, et al.
The Prostate|September 21, 2005
Numerical and functional assessment of blood dendritic cells in prostate cancer patientsRay Wilkinson, Andrew J Kassianos, Peter Swindle, et al.
World Journal of Urology|August 5, 2020
PSA-based machine learning model improves prostate cancer risk stratification in a screening populationMarlon Perera, Rohan Mirchandani, Nathan Papa, et al.
European Urology Focus|December 18, 2021
Advancing Traditional Prostate-specific Antigen Kinetics in the Detection of Prostate Cancer: A Machine Learning ModelMarlon Perera, Lewis Smith, Ian Thompson, et al.
The Journal of Urology|August 12, 2005
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimensPeter Swindle, James A Eastham, Makoto Ohori, et al.
The Journal of Urology|April 25, 2008
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimensPeter Swindle, James A Eastham, Makoto Ohori, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2015
A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancerRebecca L Prue, Frank Vari, Kristen J Radford, et al.
Pageof 2